Systemic lupus erythematosus MRI: Difference between revisions
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
On gastrointerstinal MRI, systemic lupus erythematosus (SLE) may be characterized by hepatomegaly, pancreatic parenchymal enlargement, and hypervascularity of mesentery. On cardiac MRI, SLE may be characterized by mitral leaflet thickening, pericardial thickness, and pericardial effusions. On neurologic MRI, SLE may be characterized by white matter lesions, changes in brain vessel blood flow, and Patchy areas of enhancement. On musculoskeletal MRI, SLE may be characterized by intramuscular edema, [[Tenosynovitis|proliferative tenosynovitis]], and [[bone marrow]] edema. | |||
== | == Key MRI findings in systemic lupus erythematosus == | ||
Most of the SLE complications can be found with other more feasible imaging techniques. So MRI is not indicated primarily in the diagnosis of most complications of SLE, but if done, the following results can be found regarding the organ system involvement: | |||
MRI is | |||
{| class="wikitable" | {| class="wikitable" | ||
! | ! | ||
!Disease | !Disease | ||
!MRI | !MRI | ||
|- | |- | ||
| rowspan=" | | rowspan="3" |Gastrointestinal system | ||
|[[Hepatitis]] | |[[Hepatitis]] | ||
| | | | ||
* | * Hepatomegly | ||
** | * Nodules that ranging around 0.5-4.5 cm in diameter | ||
** T2: nonspecific, increased periportal oedema | |||
|- | |- | ||
|[[Acute pancreatitis]] | |[[Acute pancreatitis]] | ||
| | | | ||
* to | * Contrast-enhanced MR is equivalent to CT in the assessment of pancreatitis | ||
* | ** Abnormalities that may be seen in the pancreas include: | ||
* | *** Parenchymal enlargement | ||
*** Surrounding retroperitoneal fat stranding | |||
*** Abscess formation | |||
**** Circumscribed fluid collection | |||
|- | |- | ||
|[[Mesenteric vascular occlusion|Mesenteric vasculitis]] | |[[Mesenteric vascular occlusion|Mesenteric vasculitis]] | ||
| | | | ||
* | * Comb sign | ||
* | ** Hypervascular appearance of the mesentery | ||
|- | |- | ||
|[[ | | rowspan="4" |Cardiac involvement | ||
|[[Mitral stenosis]] | |||
| | | | ||
* | * Mitral leaflet thickening | ||
* | * Reduced diastolic opening | ||
* Abnormal valve motion toward the left ventricular outflow tract | |||
* | |||
|- | |- | ||
| | |[[Pericarditis|Acute pericarditis]] | ||
| | | | ||
* The normal pericardial thickness is considered 2 mm while a thickness of over 4 mm suggests a [[pericarditis]] | |||
|- | |- | ||
| | |[[Pericardial effusion]] | ||
| | | | ||
* Fluid [[density]] material surrounding the heart | |||
|- | |- | ||
|[[Myocarditis]] | |[[Myocarditis]] | ||
| | | | ||
* | * Regional or global wall motion abnormalities | ||
* | * Pericardial effusion | ||
** regional vasodilatation and increased blood volume | ** Early postcontrast enhancement due to regional vasodilatation and increased blood volume, secondary to the inflammation | ||
|- | |- | ||
| | | rowspan="4" |Neurological involvement | ||
|General | |General | ||
| | | | ||
Line 119: | Line 62: | ||
* Periventricular hyperintensities | * Periventricular hyperintensities | ||
* Detects clinically silent lesions | * Detects clinically silent lesions | ||
|- | |- | ||
|[[Stroke]] | |[[Stroke]] | ||
| | | | ||
* | * Changes in brain vessel blood flow (occlusion on MRA) | ||
* after 6 hours | * No parenchymal changes | ||
* Slow or stagnant flow in vessels as a loss of normal flow void | |||
* High T2 signal after 6 hours of stoke | |||
|- | |- | ||
|[[Neuropathies]] | |[[Neuropathies]] | ||
| | | | ||
* Optic neuritis | * [[Optic neuritis]] | ||
** | ** Retrobulbar intra-orbital segment of the optic nerve appears swollen | ||
*** High T2 signal that may persists and be permanent | |||
** Chronic involvement of optic nerve | |||
*** Atrophied nerve | |||
*** Contrast enhancement of the nerve, best seen with fat-suppressed T1 coronal images | |||
|- | |- | ||
|Autoimmune encephalitis | |Autoimmune encephalitis | ||
| | | | ||
* Mostly in temporal lobes and limbic systems | |||
* Bilateral involvement is most common (60%), although often asymmetric | |||
* [[Cortical area|Cortical]] thickening | |||
* Increased T2/FLAIR signal intensity of affected regions | |||
* Patchy areas of enhancement | |||
|- | |- | ||
| rowspan="4" |Musculoskeletal involvement | |||
|Raynaud phenomen | |||
| | | | ||
* Contrast-enhanced MR angiograph | |||
** Characteristic narrowing of digital vessels | |||
** Tapering of digital vessels | |||
|- | |- | ||
|Myositis | |Myositis | ||
| | | | ||
* Intramuscular edema (increased high T2 signal) | |||
|- | |- | ||
|[[Arthritis]] | |[[Arthritis]] | ||
| | | | ||
* Capsular swelling | * Capsular swelling | ||
* Proliferative tenosynovitis | * [[Tenosynovitis|Proliferative tenosynovitis]] | ||
* Synovial overgrowth | * [[Synovial]] overgrowth | ||
|- | |- | ||
|[[Osteonecrosis]] ([[Avascular necrosis]]) | |[[Osteonecrosis]] ([[Avascular necrosis]]) | ||
| | | | ||
* Lack of enhancement and devascularized areas on gadolinium-enhanced MR imaging | |||
* Bone marrow edema on MRI | |||
* Low-signal-intensity marginal areas on standard spin-echo T1- and T2-weighted images | |||
* Intermediate to high signal intensity inside bone tissue on T2-weighted images, producing a line of low signal intensity with an adjacent high-signal-intensity line | |||
* High signal intensity on T2-weighted images due to subchondral fractures that may be accompanied by fluid signal intensity or edema | |||
* Low signal intensity on T2-weighted images due to collapse of the articular surface | |||
* Early or subtle insufficiency fractures especially on T2-weighted MR imaging | |||
** In characteristic stress locations insufficiency fractures may appear as areas of high signal intensity due to bone marrow edema | |||
|} | |} | ||
==References== | ==References== |
Revision as of 19:56, 17 July 2017
Systemic lupus erythematosus Microchapters |
Differentiating Systemic lupus erythematosus from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Systemic lupus erythematosus MRI On the Web |
American Roentgen Ray Society Images of Systemic lupus erythematosus MRI |
Directions to Hospitals Treating Systemic lupus erythematosus |
Risk calculators and risk factors for Systemic lupus erythematosus MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
On gastrointerstinal MRI, systemic lupus erythematosus (SLE) may be characterized by hepatomegaly, pancreatic parenchymal enlargement, and hypervascularity of mesentery. On cardiac MRI, SLE may be characterized by mitral leaflet thickening, pericardial thickness, and pericardial effusions. On neurologic MRI, SLE may be characterized by white matter lesions, changes in brain vessel blood flow, and Patchy areas of enhancement. On musculoskeletal MRI, SLE may be characterized by intramuscular edema, proliferative tenosynovitis, and bone marrow edema.
Key MRI findings in systemic lupus erythematosus
Most of the SLE complications can be found with other more feasible imaging techniques. So MRI is not indicated primarily in the diagnosis of most complications of SLE, but if done, the following results can be found regarding the organ system involvement:
Disease | MRI | |
---|---|---|
Gastrointestinal system | Hepatitis |
|
Acute pancreatitis |
| |
Mesenteric vasculitis |
| |
Cardiac involvement | Mitral stenosis |
|
Acute pericarditis |
| |
Pericardial effusion |
| |
Myocarditis |
| |
Neurological involvement | General |
|
Stroke |
| |
Neuropathies |
| |
Autoimmune encephalitis |
| |
Musculoskeletal involvement | Raynaud phenomen |
|
Myositis |
| |
Arthritis |
| |
Osteonecrosis (Avascular necrosis) |
|